期刊文献+

慢性肺炎衣原体感染是慢性阻塞性肺疾病的危险因子 被引量:2

Chronic pneumonia chlamydia infection was risk factor for chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的:探讨慢性肺炎衣原体感染与慢性阻塞性肺疾病(COPD)的关系。方法:收治慢性阻塞性肺疾病患者107例作为研究组,选取体检患者100例作为对照组。研究组给予常规性治疗。比较两组治疗前后慢性肺炎衣原体感染率。结果:研究组慢性肺炎衣原体感染率明显高于对照组,差异具有统计学意义(P<0.05)。研究组治疗后慢性肺炎衣原体感染率低于治疗前,差异具有统计学意义(P<0.05)。结论:慢性肺炎衣原体感染是慢性阻塞性肺疾病的危险因子,可以作为诊断慢性阻塞性肺疾病的有效依据,能有效判断慢性阻塞性肺疾病的治疗效果。 Objective:To explore the relationship between chronic pneumonia chlamydia infection and chronic obstructive pulmonary disease(COPD).Methods:107 cases of patients with chronic obstructive pulmonary disease were as the research group.100 cases of patients with physical examination were as the control group.The research group were given routine therapy.The chronic pneumonia chlamydia infections rate of the two groups before and after the treatment were compared.Results:The chronic pneumonia chlamydia infections rate of the research group were significantly higher than those of the control group,and the difference was statistically significant(P<0.05).After the treatment,the chronic pneumonia chlamydia infections rate of the research group were significantly lower than before treatment,and the difference was statistically significant(P<0.05).Conclusion:Chronic chlamydia pneumoniae infection was risk factor for chronic obstructive pulmonary disease(COPD),which could be used as an effective basis for diagnosis of chronic obstructive pulmonary disease(COPD) and judge the curative effect of chronic obstructive pulmonary disease(COPD) effectively.
作者 韩辉
出处 《中国社区医师》 2015年第21期40-41,共2页 Chinese Community Doctors
关键词 慢性肺炎衣原体感染 慢性阻塞性肺疾病 危险因子 Chronic pneumoniae chlamydia infection Chronic obstructive pulmonary disease Risk factors
  • 相关文献

参考文献5

二级参考文献52

  • 1刘慧,张天托,周宇麒,张贤兰,黄静.COPD急性加重期肺炎衣原体感染的临床分析[J].临床肺科杂志,2004,9(6):646-648. 被引量:6
  • 2王宋平,熊瑛,王鸿程.慢性阻塞性肺疾病的发病机制[J].临床肺科杂志,2005,10(4):521-522. 被引量:45
  • 3刘丽娟,张永红,佟伟军,刘永跃,黄桂蓉,张显玉.肺炎衣原体感染与高血压关系的血清流行病学研究[J].中华流行病学杂志,2006,27(10):845-848. 被引量:6
  • 4刘广超,吴移谋.肺炎嗜衣原体诊断方法的研究进展[J].微生物学免疫学进展,2006,34(4):71-75. 被引量:9
  • 5Groneberg DA, Chung KF. Models of chronic obstructive pulmonary disease[J]. Respir Res, 2004,5 : 18.
  • 6Branden E, Koyi H, Gnarpe J, et al. Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD [J]. Respir Med,2005, 99(1) :20-26.
  • 7Muhlestein JB, Hammond EH,Carlquist JF, et al. Increase incidence of Chlamydia species within the coronary arteries of patients with symptomatic atheroselerotic versus other forms of cardiovascular disease[J].J Am Coll Cardiol, 1996, 27(7) : 1555- 1561.
  • 8Fan P, Dong F, Huang Y, et al. Chlamydia pneumoniae secrection of a proteases-like activity factor for degrading host cell transcription factor required for major histocompatibility complex antigen expresion[J]. Infection Immunity, 2002, 70(1) :345- 349.
  • 9Lee PI, Wu MH, Huang LM, et al. An open, randomized,comparative study of clarithromycin and erythromycin in the treatment of children with community acquired pneumonia[J]. J Microbiol Immunol Infect, 2008, 41 (1) : 54-61.
  • 10Branden E, Koyi H, Gnarpe J, et al. Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection[J]. Scand J Infect Dis, 2004, 36(11-12) :811-816.

共引文献33

同被引文献13

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部